Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3311 results

Sort By:

Vibrotactile Coordinated Reset for the Treatment of Post Surgery Refractory Parkinson's Disease Patients

Study ID: NCT05558189
Start Date: 2025-08-20
End Date: 2026-11-21
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Vibrotactile Coordinated Reset (vCR)

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

Study ID: NCT06655480
Start Date: 2024-12-18
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

[ARNI + SGLTi + AMR]

[SGLTi + previously taken RAAS blocker]

Sponsor

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Source: clinicaltrials.gov

Share:
Add to list

Targeting Vascular INflammation in Patients with Community-Acquired Pneumonia

Study ID: NCT06710080
Start Date: 2024-12-15
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase3

No. of Participants

168

Intervention / Treatment

Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]

Placebo

Sponsor

Ottawa Heart Institute Research Corporation

Source: clinicaltrials.gov

Share:
Add to list

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Study ID: NCT06513962
Start Date: 2025-02-10
End Date: 2029-10-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

60

Intervention / Treatment

Best Practice

Biospecimen Collection

Electronic Health Record Review

Survey Administration

Triptorelin Pamoate

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Concept Map Use in Nursing Practice

Study ID: NCT06451991
Start Date: 2025-03-03
End Date: 2025-04-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

66

Intervention / Treatment

Use of concept map in clinical practice in nursing students

Sponsor

Nilgun Sert Bas

Source: clinicaltrials.gov

Share:
Add to list

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24

Study ID: NCT06646562
Start Date: 2025-01-30
End Date: 2027-01-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

120

Intervention / Treatment

Cabotegravir LA + Rilpivirine LA

Sponsor

Foundation for Health Training and Research of the Region of Murcia

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Study ID: NCT06317662
Start Date: 2025-01-26
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

171

Intervention / Treatment

Asparaginase Erwinia chrysanthemi

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration

Calaspargase Pegol

Computed Tomography

Cyclophosphamide

Cytarabine

Daunorubicin

Dexamethasone

Doxorubicin

Echocardiography

FDG-Positron Emission Tomography

Leucovorin

Lumbar Puncture

Magnetic Resonance Imaging

Mercaptopurine

Methotrexate

Multigated Acquisition Scan

Pegaspargase

Prednisolone

Prednisone

Therapeutic Hydrocortisone

Thioguanine

Venetoclax

Vincristine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

Study ID: NCT06704672
Start Date: 2024-12-15
End Date: 2025-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

270

Intervention / Treatment

Accu-Chek SmartGuide CGM Solution

Accu-Chek SmartGuide Sensor and Blinded Apps

SMBG Device

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)

Study ID: NCT04430972
Start Date: 2025-09
End Date: 2026-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Aortic valve replacement

Sponsor

Barts & The London NHS Trust

Source: clinicaltrials.gov

Share:
Add to list

Orofacial Functions in Individuals With and Without Molar Incisor Hypomineralization

Study ID: NCT06692257
Start Date: 2025-03-01
End Date: 2025-11-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

56

Intervention / Treatment

Observation

Sponsor

University of Nove de Julho

Source: clinicaltrials.gov

Share:
Add to list